Novartis cancer drug gets Phl FDA approval
Philippine Star
MANILA, Philippines - The Novartis anti-cancer drug everolimus, in combination with aromatase inhibitor, is now approved in the Philippines for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer, ...
Europe Approves Everolimus in Advanced Breast CancerThe Oncology Report
EU approves new breast cancer drugHealthcare Today

all 5 news articles »